藥物試驗顯示有望改善輪班工作者的警覺性
Drug trial shows promise for improving alertness in shift workers
輪班工作睡眠障礙影響了這些工作者中高達40%的人,導致極度的日間嗜睡與失眠。
Shift Work Sleep Disorder (SWSD) impacts up to 40% of these workers, causing extreme daytime sleepiness and insomnia.
雖然咖啡因或處方藥物莫達非尼等興奮劑是標準療法,科學家目前正在測試新型的標靶藥物,旨在透過避開有依賴風險的傳統路徑,更安全地提升警覺性。
While stimulants like caffeine or prescription modafinil are standard, scientists are now testing new, targeted drugs designed to promote alertness more safely by avoiding traditional pathways that risk dependency.
有效地管理SWSD需要全盤的策略,包括策略性的小睡、受控的光照療法以及嚴格的睡眠衛生。
Managing SWSD effectively requires a holistic approach, including strategic napping, controlled light therapy, and rigorous sleep hygiene.
